Detalhe da pesquisa
1.
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.
Ann Surg Oncol
; 31(3): 1919-1932, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170408
2.
Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study.
Br J Surg
; 111(3)2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456678
3.
Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study.
Ann Surg Oncol
; 30(3): 1463-1473, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539580
4.
Diagnostic performance of endoscopic tissue acquisition for pancreatic ductal adenocarcinoma in the PREOPANC and PREOPANC-2 trials.
HPB (Oxford)
; 25(10): 1161-1168, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211461
5.
Diagnostic accuracy of endoscopic ultrasonography-guided tissue acquisition prior to resection of pancreatic carcinoma: a nationwide analysis.
HPB (Oxford)
; 25(11): 1438-1445, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550169
6.
Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma.
Int J Cancer
; 150(10): 1654-1663, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34935139
7.
Sensitivity of CT, MRI, and EUS-FNA/B in the preoperative workup of histologically proven left-sided pancreatic lesions.
Pancreatology
; 22(1): 136-141, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34857486
8.
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study.
J Natl Compr Canc Netw
; 20(7): 783-791.e1, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35830887
9.
Endoscopic ultrasonography as additional preoperative workup is valuable in half of the patients with a pancreatic body or tail lesion.
HPB (Oxford)
; 24(6): 809-816, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34732301
10.
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Ann Surg Oncol
; 28(13): 8297-8308, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142290
11.
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.
J Clin Oncol
; 42(12): 1357-1367, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315954
12.
Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res
; 29(7): 1368-1374, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795432
13.
Targeted next-generation sequencing has incremental value in the diagnostic work-up of patients with suspect pancreatic masses; a multi-center prospective cross sectional study.
PLoS One
; 18(1): e0280939, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696439
14.
Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials.
Eur J Cancer
; 160: 140-149, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838371
15.
Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma.
J Am Coll Surg
; 235(2): 342-349, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839413
16.
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium.
J Natl Cancer Inst
; 114(5): 695-703, 2022 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157075
17.
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.
Front Immunol
; 13: 898498, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36091056
18.
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
J Clin Oncol
; 40(11): 1220-1230, 2022 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084987
19.
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.
Ther Adv Med Oncol
; 13: 17588359211033704, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34422118
20.
Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer.
Front Oncol
; 10: 41, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083002